Posts for Ticker ‘HLS’

Top 10 Analyst Upgrades & Downgrades (AMED, BNI, CMCSA, CSX, DCP, FISV, GMR, HLS, STJ, TWC)

These are ten of the top pre-market analyst upgrades, downgrades, and initiation calls we have seen from Wall Street early this Wednesday morning with close to two hours until the market opens:

Amedisys (AMED) Cut to Neutral at UBS.
Burlington Northern Santa Fe (BNI) Started as Outperform at Baird.
Comcast (CMCSA) Started as Overweight at JPMOrgan.
CSX (CSX) Started as Outperform at Baird.
Dyncorp (DCP) Started as Buy at SunTrust.
Fiserv (FISV) Started as Buy at Citigroup.
General Maritime Corp. (GMR) Raised to Outperform at FBR.
HealthSouth Corp. (HLS) Started as Outperform at Baird.
St. Jude Medical (STJ) Raised to Outperform at Wells Fargo.
Time Warner Cable (TWC) Started as Overweight at JPMorgan.

JON C. OGG

Posted on: August 26, 2009 – 7:45 am in Analyst Calls, , , , , , , , , ,

Top Pre-Market Analyst Upgrades (EQIX, HLS, ITRI, MPEL, RTP, RTIX, UL, WSM)

Money_stack_picThese are the few upgrades and positive research calls we have seen from Wall Street analysts this Wednesday morning:

  • Equinix (EQIX) Started as Overweight at JPMorgan.
  • Healthsouth (HLS) Raised to Buy at Jefferies.
  • Itron (ITRI) Raised to Buy at UBS.
  • Melco Crown PBL (MPEL) Raised to Buy but target cut at Goldman Sachs.
  • Rio Tinto (RTP) Raised to Buy at Canaccord.
  • RTI Biologics (RTIX) Started as Buy at Canaccord.
  • Unilever (UL) Started as Buy at Jefferies.
  • William Sonoma (WSM) Raised to Neutral from Sell at UBS.

Jon C. Ogg
November 26, 2008

Posted on: November 26, 2008 – 7:37 am in Analyst Calls, , , , , , , ,

Cramer’s Sell Block (May 10, 2007)

On tonight’s Sell Block on CNBC’s MAD MONEY, Jim Cramer reviewed many of his picks you need to sell:

He said the CEO of Syntax-Brillian (BRLC) is one he doesn’t trust and he’s against the stock right now.  If you read my own commentary regularly then this may sound familiar after I said they can’t be trusted.

HealthSouth (HLS) is one where Cramer is no longer on the fence and you have to sell it.  The debt credit spreads are bad.

Because of the potential backlash on drug stocks, he wants to take the 16% gain on Novo Nordisk (NVO).

He wants to stick with McDermott (MDR) at $75, Foster Wheeler (FWLT) sell at $100, Fluor (FLR) at $115.

Dynegy (DYN) is being run well and he doesn’t think it needs to go down.

Cisco Sytems (CSCO) is one he liked repeatedly and he thought it would go up and it didn’t; But Cramer said he is not going negative and he is saying to not sell it.  He would be a buyer if you haven’t bought.  As a reminder this was Cramer’s #3 Top Growth Pick for 2007.

Jon C. Ogg
May 10, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Posted on: May 10, 2007 – 5:52 pm in Cramer, , , , , , , ,